FORM N-PX Annual Report of Proxy Voting Record of Registered Management Investment Companies Filed on Form N-PX
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chronology, 1963–89
Chronology, 1963–89 This chronology covers key political and economic developments in the quarter century that saw the transformation of the Euromarkets into the world’s foremost financial markets. It also identifies milestones in the evolu- tion of Orion; transactions mentioned are those which were the first or the largest of their type or otherwise noteworthy. The tables and graphs present key financial and economic data of the era. Details of Orion’s financial his- tory are to be found in Appendix IV. Abbreviations: Chase (Chase Manhattan Bank), Royal (Royal Bank of Canada), NatPro (National Provincial Bank), Westminster (Westminster Bank), NatWest (National Westminster Bank), WestLB (Westdeutsche Landesbank Girozentrale), Mitsubishi (Mitsubishi Bank) and Orion (for Orion Bank, Orion Termbank, Orion Royal Bank and subsidiaries). Under Orion financings: ‘loans’ are syndicated loans, NIFs, RUFs etc.; ‘bonds’ are public issues, private placements, FRNs, FRCDs and other secu- rities, lead managed, co-managed, managed or advised by Orion. New loan transactions and new bond transactions are intended to show the range of Orion’s client base and refer to clients not previously mentioned. The word ‘subsequently’ in brackets indicates subsequent transactions of the same type and for the same client. Transaction amounts expressed in US dollars some- times include non-dollar transactions, converted at the prevailing rates of exchange. 1963 Global events Feb Canadian Conservative government falls. Apr Lester Pearson Premier. Mar China and Pakistan settle border dispute. May Jomo Kenyatta Premier of Kenya. Organization of African Unity formed, after widespread decolonization. Jun Election of Pope Paul VI. Aug Test Ban Take Your Partners Treaty. -
Northern Rock Plc - HM Treasury
[ARCHIVED CONTENT] Northern Rock plc - HM Treasury This snapshot, taken on 07/04/2010, shows web content acquired for preservation by The National Archives. External links, forms and search may not work in archived websites and contact details are likely to be out of date. More about the UK Government Web Archive See all dates available for this archived website The UK Government Web Archive does not use cookies but some may be left in your browser from archived websites. More about cookies 16/08 Help | Contact us | Access keys | Site map | A-Z 17 February 2008 Northern Rock plc Newsroom & speeches Home > Newsroom & speeches > Press notices > 2008 Press Notices > February > Northern Rock plc 1. The Government has today decided to bring forward legislation that will enable Northern Rock plc to be taken into a period of temporary Home public ownership. The Government has taken this decision after full consultation with the Bank of England and the Financial Services Authority. The Government's financial adviser, Goldman Sachs, has concluded from a financial point of view that a temporary period of Budget public ownership better meets the Government's objective of protecting taxpayers. 2. Northern Rock will be open for business as usual tomorrow morning and thereafter. Branches will be open; internet and call centre Pre-Budget Report services will operate as normal. All Northern Rock employees remain employed by the company. Depositors' money remains absolutely safe and secure. The Government's guarantee arrangements remain in place and will continue to do so. Borrowers will continue to make their payments in the normal way. -
Cohen & Steers Preferred Securities and Income Fund
Cohen & Steers Preferred Securities and Income Fund As of 06/30/2021 Current % of Total Security Name Sector Market Value Market Value Wells Fargo & Company Flt Perp Banking $219,779,776.15 1.81 % Charles Schwab Corp Flt Perp Sr:I Banking $182,681,675.00 1.51 % Bp Capital Markets Plc Flt Perp Energy $158,976,029.00 1.31 % Bank of America 6.25% Banking $148,052,279.38 1.22 % Bank of Amrica 6.10% Banking $144,075,863.52 1.19 % Citigroup Inc Flt Perp Banking $139,736,756.25 1.15 % Emera 6.75% 6/15/76-26 Utilities $134,370,096.24 1.11 % Transcanada Trust 5.875 08/15/76 Pipeline $116,560,837.50 0.96 % JP Morgan 6.75% Banking $116,417,211.75 0.96 % JP Morgan 6.1% Banking $115,050,549.38 0.95 % Credit Suisse Group AG 7.5 Perp Banking $112,489,090.00 0.93 % Enbridge Inc Flt 07/15/80 Sr:20-A Pipeline $101,838,892.50 0.84 % Charles Schwab Corp Flt Perp Sr:G Banking $101,715,980.40 0.84 % Bank of America Corp 5.875% Perp Banking $99,269,540.97 0.82 % Sempra Energy Flt Perp Utilities $97,680,337.50 0.81 % BNP Paribas 7.375% Banking $96,328,288.48 0.79 % Jpmorgan Chase & Co Flt Perp Sr:Kk Banking $95,672,863.00 0.79 % Metlife Capital Trust IV 7.875% Insurance $94,971,600.00 0.78 % Citigroup 5.95% 2025 Call Banking $89,482,599.30 0.74 % Transcanada Trust Flt 09/15/79 Pipeline $88,170,468.75 0.73 % Ally Financial Inc Flt Perp Sr:C Banking $86,422,336.00 0.71 % Banco Santander SA 4.75% Flt Perp Banking $83,189,000.00 0.69 % American Intl Group 8.175% 5/15/58 Insurance $82,027,104.20 0.68 % Prudential Financial 5.625% 6/15/43 Insurance $80,745,314.60 0.67 -
Annual Review 2005
GS2184_Review_A\W2.qxd 7/3/06 4:58 pm Page fc1 Annual Review 2005 human being Do more, feel better, live longer GS2184_Review_A\W2.qxd 9/3/06 1:28 pm Page ifc2 01 An interview with Sir Christopher Gent, Chairman, and JP Garnier, Chief Executive Officer 05 Tachi Yamada, Chairman, Research & Development, Pharmaceuticals 06 Jean Stéphenne, President and General Manager, GSK Biologicals 08 John Clarke, President, Consumer Healthcare 11 David Stout, President, Pharmaceutical Operations 14 Performance highlights 15 Business operating review 18 The Board 19 The Corporate Executive Team 20 Summary remuneration report 23 Corporate governance 24 Responsibility statements 25 Summary financial statements 26 Summary information under US GAAP 27 Shareholder information 29 Chairman and CEO’s closing letter JP Garnier (left) and Sir Christopher Gent (right) GS2184_Review_A\W2.qxd 7/3/06 5:01 pm Page 01 “Discovering important medicines, eradicating diseases, improving the quality of people’s lives and making medicines available to a greater number of people. This is what we do – and what we do matters to people.” JP Garnier, Chief Executive Officer An interview with Sir Christopher Gent, Chairman and JP Garnier, Chief Executive Officer 2005: a year of success and progress “Thanks to the efforts of our employees around the company’s pipeline is one of the largest and most world, 2005 was a very successful year for GSK,” says promising in the industry, with 149 projects in clinical JP Garnier, Chief Executive Officer. “Not only was it development (as at the end of February 2006), our best year ever from a financial standpoint, we also including 95 new chemical entities (NCEs), 29 product made substantial progress with our pipeline of line extensions (PLEs) and 25 vaccines. -
Annual Report and Accounts 2018 Strategic Report
Annual Report and Accounts 2018 Strategic report Page Principal activities and operating segments Strategic report The Group serves customers across the UK and Western Europe with Presentation of information 1 a range of retail and commercial banking products. A wide range of RBS Group ring-fencing 1 personal products are offered including current accounts, credit cards, Principal activities and operating segments 1 personal loans and mortgages. Personal & Business Banking (PBB) Performance overview 1 serves individuals and mass affluent customers together with small Board of directors and secretary 2 businesses through the Group’s network of branches and direct channels, including the internet, mobile and telephony. Commercial & Top and emerging risks 3 Private Banking (CPB) provides services to private, corporate and Financial review 4 commercial customers. NatWest is the main provider of shared service Capital and risk management 9 activities for the RBS Group. This includes the provision of Treasury Report of the directors 58 services on behalf of the RFB and RBS Group. Statement of directors’ responsibilities 61 Financial Statements 62 The reportable operating segments are as follows: Risk factors 132 Personal & Business Banking comprises one reportable segment: UK Forward-looking statements 142 Personal & Business Banking (UK PBB). UK PBB serves individuals and mass affluent customers in the UK together with small businesses Presentation of information (generally up to £2 million turnover). UK PBB includes Ulster Bank National Westminster Bank Plc (‘NatWest’ or the ‘Bank’) is a wholly- customers in Northern Ireland. owned subsidiary of NatWest Holdings Limited (‘NatWest Holdings’, ‘NWH’ or ‘the intermediate holding company. The ultimate holding Commercial & Private Banking comprises two reportable segments: company is The Royal Bank of Scotland Group plc (the ‘ultimate Commercial Banking and Private Banking. -
Natwest Group
Prospectus dated 26 November 2020 NatWest Group plc (incorporated in Scotland with limited liability under the Companies Acts 1948 to 1980, registered number SC045551) £40,000,000,000 Euro Medium Term Note Programme On 22 February 1994, NatWest Markets Plc (formerly known as The Royal Bank of Scotland plc) entered into a £1,500,000,000 (since increased from time to time to £40,000,000,000) Euro Medium Term Note Programme (the "Programme") and issued a prospectus on that date describing the Programme. Further prospectuses describing the Programme were issued by NatWest Group plc (the "Issuer" or "NatWest Group") and NatWest Markets Plc, the latest prospectus being issued on 21 November 2019. This Prospectus supersedes any previous prospectus. Any Notes (as defined below) issued under the Programme on or after the date of this Prospectus are issued subject to the provisions described herein. This does not affect any Notes issued before the date of this Prospectus. Under the Programme, the Issuer may, subject to compliance with all relevant laws, regulations and directives, from time to time, issue notes (the "Notes") denominated in any currency agreed by the Issuer and the relevant Dealer(s) (as defined below). The maximum aggregate nominal amount of all Notes from time to time outstanding will not exceed £40,000,000,000 (or its equivalent in other currencies, subject to increase as provided herein). Notes to be issued under the Programme may comprise (i) unsubordinated Notes (the "Ordinary Notes") and (ii) Notes which are subordinated as described herein with a maturity date and with terms capable of qualifying as Tier 2 Capital (as defined herein) (the "Tier 2 Notes"). -
In This Section
Strategic report In this section Chairman’s statement 2 CEO’s review 4 Business overview 6 The global context 8 Our business model 12 Our strategic priorities 14 How we performed 16 Risk management 18 Grow 20 Deliver 32 Simplify 44 Our financial architecture 48 Responsible business 50 Financial review 58 Strategic report Chairman’s statement Chairman’s statement To shareholders The value of the significant changes that have been made in recent years is evidenced in our performance this year “ Since Sir Andrew became It is clear from the following pages that Through the Audit & Risk Committee, we the Group made good progress against oversee the issues and challenges faced by CEO, the company has its strategy in 2013. management, and encourage the creation of an environment in which GSK can achieve The Board believes the business is seeing returned £30 billion its strategic ambitions in a responsible and the benefits of the significant changes the sustainable manner. to shareholders.” management team has driven over recent years to deliver sustainable growth, reduce risk and I have no doubt that commercial success is enhance returns to shareholders. directly linked to operating in a responsible way and which meets the changing expectations of The notably strong performance from the society. In this respect, the company continues R&D organisation in 2013 – with six major to adopt industry-leading positions on a range new product approvals in areas including of issues. respiratory disease, HIV and cancer – is critical to the longer-term prospects of the The announcement of plans during 2013 to Group. -
Natwest Markets Plc Registration Document
Dated 22 March 2019 NatWest Markets Plc (incorporated in Scotland with limited liability under the Companies Acts 1948 to 1980, registered number SC090312) Registration Document TABLE OF CONTENTS Page Introduction ................................................................................................................................................................... 1 Documents Incorporated by Reference .......................................................................................................................... 2 Important Information for Investors .............................................................................................................................. 3 Risk Factors ................................................................................................................................................................. 13 Selected Consolidated Financial Information and Other Data ..................................................................................... 32 Operating and Financial Review ................................................................................................................................. 35 Description of the Group ............................................................................................................................................. 79 Selected Statistical Data and Other Information .......................................................................................................... 97 Risk Management ..................................................................................................................................................... -
Natwest Group United Kingdom
NatWest Group United Kingdom Active This profile is actively maintained Send feedback on this profile Created before Nov 2016 Last update: Feb 23 2021 About NatWest Group NatWest Group, founded in 1727, is a British banking and insurance holding company based in Edinburgh, Scotland. Its main subsidiary companies are The Royal Bank of Scotland, NatWest, Ulster Bank and Coutts. Prior to a name-change in July 2020, it was known as Royal Bank of Scotland (RBS) Group. After a massive bailout in 2008, a majority of RBS' shares were purchased by the UK Government. In 2014 the bank embarked on a restructuring process that saw it refocus on its business in the UK and Ireland. As part of this process it divested its ownership of Citizens Financial Group, the 13th largest bank in the United States, in 2015. As of 2020 it remains 61.93% UK Government owned, via UK Financial Investments (UKFI). Website https://www.natwestgroup.com/ Headquarters 36 St Andrew Square EH2 2YB Edinburgh Scotland United Kingdom CEO/chair Alison Rose CEO Supervisor Bank of England Annual report Annual report 2020 Ownership listed on London Stock Exchange Natwest Group is majority-owned by the UK government since 2008, which currently holds 61.93 % of the shares. Complaints NatWest Group does not operate a complaints channel for individuals and communities that may be adversely affected by and its finance. However, the bank can be contacted via the contact form here (e.g. using ‘General Service’ as account type). grievances Stakeholders may raise complaints via the OECD National Contact Points (see OECD Watch guidance). -
Ftse4good UK 50
2 FTSE Russell Publications 19 August 2021 FTSE4Good UK 50 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.81 UNITED GlaxoSmithKline 5.08 UNITED Rentokil Initial 0.67 UNITED KINGDOM KINGDOM KINGDOM Anglo American 2.56 UNITED Halma 0.74 UNITED Rio Tinto 4.68 UNITED KINGDOM KINGDOM KINGDOM Antofagasta 0.36 UNITED HSBC Hldgs 6.17 UNITED Royal Dutch Shell A 4.3 UNITED KINGDOM KINGDOM KINGDOM Associated British Foods 0.56 UNITED InterContinental Hotels Group 0.64 UNITED Royal Dutch Shell B 3.75 UNITED KINGDOM KINGDOM KINGDOM AstraZeneca 8.25 UNITED International Consolidated Airlines 0.47 UNITED Schroders 0.28 UNITED KINGDOM Group KINGDOM KINGDOM Aviva 1.15 UNITED Intertek Group 0.65 UNITED Segro 0.95 UNITED KINGDOM KINGDOM KINGDOM Barclays 2.1 UNITED Legal & General Group 1.1 UNITED Smith & Nephew 0.99 UNITED KINGDOM KINGDOM KINGDOM BHP Group Plc 3.2 UNITED Lloyds Banking Group 2.39 UNITED Smurfit Kappa Group 0.74 UNITED KINGDOM KINGDOM KINGDOM BT Group 1.23 UNITED London Stock Exchange Group 2.09 UNITED Spirax-Sarco Engineering 0.72 UNITED KINGDOM KINGDOM KINGDOM Burberry Group 0.6 UNITED Mondi 0.67 UNITED SSE 1.13 UNITED KINGDOM KINGDOM KINGDOM Coca-Cola HBC AG 0.37 UNITED National Grid 2.37 UNITED Standard Chartered 0.85 UNITED KINGDOM KINGDOM KINGDOM Compass Group 1.96 UNITED Natwest Group 0.77 UNITED Tesco 1.23 UNITED KINGDOM KINGDOM KINGDOM CRH 2.08 UNITED Next 0.72 UNITED Unilever 7.99 UNITED KINGDOM KINGDOM -
FTSE Factsheet
FTSE COMPANY REPORT Share price analysis relative to sector and index performance Bank Pekao SA GDR (REG S) TICKER Banks — USD 28 at close 21 April 2021 Absolute Relative to FTSE UK All-Share Sector Relative to FTSE UK All-Share Index PERFORMANCE 21-Apr-2015 1D WTD MTD YTD Absolute - - - - Rel.Sector - - - - Rel.Market - - - - VALUATION Data unavailable Trailing PE - EV/EBITDA - PB - PCF - Div Yield - Price/Sales - Net Debt/Equity - Div Payout - ROE - DESCRIPTION Data unavailable The Bank is a universal commercial bank, offering a broad range of banking services on domestic and foreign financial markets, provided to retail and corporate clients, in compliance with the scope of services, set forth in the Bank's Articles of Association. Past performance is no guarantee of future results. Please see the final page for important legal disclosures. 1 of 4 FTSE COMPANY REPORT: Bank Pekao SA GDR (REG S) 21 April 2021 Valuation Metrics Price to Earnings (PE) EV to EBITDA Price to Book (PB) Data unavailable Lloyds Banking Group 34.6 Standard Chartered 28.4 Bank of Georgia Group 1.0 Banks 30.3 Lloyds Banking Group 22.6 TBC Bank Group 0.8 HSBC Hldgs 28.6 HSBC Hldgs 22.0 HSBC Hldgs 0.7 Close Brothers Group 21.4 Banks 18.0 Lloyds Banking Group 0.6 Barclays 21.1 Close Brothers Group 15.8 Banks 0.6 Investec 2.1 Bank of Georgia Group 7.4 Natwest Group 0.5 Metro Bank -0.7 Barclays 6.4 Barclays 0.5 Virgin Money UK -12.4 Metro Bank 0.0 Standard Chartered 0.4 Natwest Group -31.5 Virgin Money UK 0.0 Metro Bank 0.2 Bank Pekao SA GDR (REG S) -120.0 Bank Pekao -
Voting/Poll Results
GLAXOSMITHKLINE PLC - RESULT OF AGM GlaxoSmithKline plc (GSK) announces that at its Annual General Meeting (AGM) today, all resolutions were passed by shareholders. GlaxoSmithKline AGM Poll Results The following table shows the votes cast for each resolution: Resolution Total votes % Total votes % Total votes Votes for* against cast withheld** Adoption of Directors’ 1 Report and Financial Statements 3,713,877,875 98.86 42,764,532 1.14 3,756,642,407 9,313,386 Approval of the 2 Remuneration Report 3,528,115,173 94.55 203,482,136 5.45 3,731,597,309 34,358,483 Election of 3 Lynn Elsenhans 3,753,666,422 99.90 3,577,765 0.10 3,757,244,187 8,711,607 Election of 4 Jing Ulrich 3,753,601,642 99.90 3,623,347 0.10 3,757,224,989 8,730,805 Election of 5 Hans Wijers 3,712,833,757 98.82 44,327,830 1.18 3,757,161,587 8,794,257 Re-election of Sir 6 Christopher Gent 3,679,075,355 97.92 78,304,492 2.08 3,757,379,847 8,575,946 Re-election of 7 Sir Andrew Witty 3,753,850,300 99.90 3,750,413 0.10 3,757,600,713 8,355,081 Re-election of Professor Sir 8 Roy Anderson 3,753,929,716 99.91 3,483,857 0.09 3,757,413,573 8,542,221 Re-election of 9 Dr Stephanie Burns 3,749,134,033 99.78 8,228,665 0.22 3,757,362,698 8,592,951 Re-election of 10 Stacey Cartwright 3,735,971,985 99.43 21,360,372 0.57 3,757,332,357 8,623,292 Re-election of 11 Simon Dingemans 3,749,800,702 99.80 7,359,374 0.20 3,757,160,076 8,795,718 Re-election of 12 Judy Lewent 3,746,232,485 99.71 11,060,403 0.29 3,757,292,888 8,662,906 Re-election of 13 Sir Deryck Maughan 3,748,191,348 99.76 9,051,199 0.24